John Reynolds
29PUBLICATIONS
116CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (29)
Sort by Publication Date:
|Jan 15, 2026
A biomarker risk assessment tool predicts infection-related mortality after allogeneic stem cell transplantation.Joanne Lay Cheng Tan, Tiffany Khong, Yu Jin Kim
|Oct 17, 2025
Measurable residual disease intervention in AML: a new therapeutic horizon.Andrew H Wei, Harry J Iland, Courtney D DiNardo
|Jul 29, 2025
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML.Rithin Nedumannil, Michael Ashby, James Rowland
|Jan 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.Harry J Iland, John Reynolds, Alan V Boddy
|Jan 18, 2025
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).Chong Chyn Chua, Sun Loo, Chun Yew Fong
|Aug 05, 2024
Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study.David T Yeung, Naranie Shanmuganathan, John Reynolds
Pageof 5
Frequent Collaborators
8 joint publications
Andrew Wei
5 joint publications
Ing Soo Tiong
4 joint publications
Harry J Iland
4 joint publications
Sun Loo
3 joint publications
Natasha S Anstee
3 joint publications
Steven W Lane
3 joint publications
Michael Ashby
3 joint publications
Chun Yew Fong
3 joint publications
Andrew W Roberts
2 joint publications
Sivalal Sadasivan
